Recent Updates
Recently added Catalysts
REGN

FDA Approves Asthma Indication for Dupixent® (dupilumab)

Monday, October 22, 2018 1 min read
Key Takeaway: FDA Approves Asthma Indication for Dupixent® (dupilumab)

Full Press Release Details

FDA Approves Asthma Indication for Dupixent® (dupilumab).
Tags: REGN Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Oct 22, 2018